Company · CIK 1598599
Innate Pharma SA
| CIK | 1598599 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | I0 |
| Listed | IPHA (Nasdaq), IPHYF (OTC) |
| First annual or quarterly report | 2020-04-24 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-276164 | 2023-12-20 | 2024-02-06 | 3 | |
| 333-252074 | 2021-01-13 | 2023-04-26 | 4 | |
| 333-233865 | 2019-09-20 | 2019-10-18 | 4 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-02-06 | 424B5Shelf takedown | 333-276164 | 0001628280-24-003513 |
| 2024-01-16 | EFFECTDeclared effective | 333-276164 | 9999999995-24-000128 |
| 2023-12-20 | F-3Shelf registered | 333-276164 | 0001628280-23-042262 |
| 2023-04-26 | 424B5Shelf takedown | 333-252074 | 0001628280-23-013213 |
| 2022-05-03 | 424B5Shelf takedown | 333-252074 | 0001628280-22-012012 |
| 2021-01-28 | EFFECTDeclared effective | 333-252074 | 9999999995-21-000330 |
| 2021-01-13 | F-3Shelf registered | 333-252074 | 0001628280-21-000427 |
| 2019-10-18 | 424B4Final prospectus | 333-233865 | 0001193125-19-270053 |
| 2019-10-16 | EFFECTDeclared effective | 333-234063 | 9999999995-19-002357 |
| 2019-10-16 | EFFECTDeclared effective | 333-233865 | 9999999995-19-002325 |
| 2019-10-04 | F-1/AAmendment | 333-233865 | 0001193125-19-262824 |
| 2019-09-20 | F-1Registration filed | 333-233865 | 0001193125-19-250682 |
| 2019-06-10 | DRSDraft made public | 377-02690 | 0000950123-19-005898 |